Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
10,404
-
Shares change
-
-15,985
-
Total reported value, excl. options
-
$142,743
-
Value change
-
-$233,541
-
Number of sells
-
-1
-
Price
-
$13.72
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q4 2023
2 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q4 2023.
AVITA Medical, Inc. - Common Stock (RCEL) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,404 shares
of 26,475,256 outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,806,149 shares), VANGUARD GROUP INC (1,392,780 shares), GEODE CAPITAL MANAGEMENT, LLC (528,657 shares), STATE STREET CORP (500,308 shares), AWM Investment Company, Inc. (496,952 shares), PURA VIDA INVESTMENTS, LLC (361,096 shares), NORTHERN TRUST CORP (225,180 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (209,257 shares), Bank of New York Mellon Corp (116,678 shares), and AMERIPRISE FINANCIAL INC (98,682 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.